$BEN

FRANKLIN TEMPLETON INC

2
0
2

No SEC Form 4 filings for $BEN in the last 30 days.

See all $BEN insider activity →
Med

BEN Assumed by UBS -- Price Target Raised to $40.00

UBS upgraded Franklin Templeton (BEN) to Buy with a $40.00 price target, a 73.91% increase. GuruFocus values BEN at $19.97, suggesting 62.6% overvaluation. The company has a GF Score of 78/100, with strengths in profitability and momentum. 6 gurus hold BEN, with mixed recent activity.

BEN sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 4 news stories mentioning BEN (FRANKLIN TEMPLETON INC). Coverage has been balanced: 2 bullish, 0 neutral, and 2 bearish.

Recent BEN coverage spans financial news, mergers & acquisitions and technology.

What's driving BEN

AlphAI scores every news story that mentions BEN with an AI model for sentiment and relevance, and aggregates insider trades from FRANKLIN TEMPLETON INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BEN

Score
$BENMed

Franklin Templeton brings its tokenized collateral service to Bybit

Franklin Templeton has expanded its tokenized collateral service to Bybit, allowing users to pledge shares in its tokenized money market funds, worth $686 million, as collateral for USDT or USDC trading credit lines while earning yield. The underlying assets are held off-exchange by ByCustody, with the value mirrored in Bybit's trading environment. This follows similar partnerships with Binance and OKX.

$BENLow

Franklin Templeton announces withdrawal from the selection process for the appointment of the Alternative Investment Fund Manager and Sole Director of Fondul Proprietatea

Franklin Templeton withdrew from the selection process for managing Fondul Proprietatea due to disagreements over evaluation. The firm will continue managing the fund until its mandate expires in 2027. Fondul Proprietatea has delivered strong returns, completed major transactions, and contributed significantly to Romania's capital market. Franklin Templeton highlights its achievements and commitment to shareholders.

$DVAMed

3 Surging Stocks That Don’t Need the AI Boom to Keep Winning

DaVita (DVA), Franklin Resources (BEN), and Archer Daniels Midland (ADM) have each gained over 30% YTD. DVA benefits from improved reimbursement rates and cost discipline, with analysts projecting 18% earnings growth. BEN has moderated outflows and beaten earnings estimates. ADM raised guidance despite volatile global trade conditions.

$BENLow

Franklin Templeton Converts Three Mutual Funds to ETFs

Franklin Templeton is converting three mutual funds to ETFs to broaden investor access while maintaining investment objectives and strategies. The funds affected include U.S. Core Equity, International Core Equity, and Emerging Market Core Equity. According to a Franklin spokesperson, the conversions aim to preserve historical performance and provide continuity for existing shareholders. David Cohne of Bloomberg Intelligence noted that the move offers immediate scale and avoids maintaining dual

$BENMedAI 8/10

Franklin Templeton Acquires Majority Stake Stoneshield

Franklin Templeton's Clarion Partners will acquire a majority stake in Stoneshield Capital, tripling its European AUM to $13B and boosting total alternative AUM above $300B. Stoneshield, with $9B in AUM, specializes in European real assets. The deal is expected to close in Q4 2026, expanding Clarion's European footprint and investment strategies.

$BENHighAI 9/10

Stoneshield Investments SL: Leading European Real Assets Manager Stoneshield Capital to Join Forces with Franklin Templeton and Clarion Partners

Franklin Templeton (BEN) will acquire a majority stake in Stoneshield Capital, a European real assets manager with €8 billion in AUM. The deal will triple Clarion's European AUM to €11 billion and increase its total AUM by 12% to €72 billion. Stoneshield's investment focus includes living, student housing, and digital infrastructure.

Related tickers